Drug Information

Drug General Information
Drug ID
D0OT0O
Former ID
DAP001383
Drug Name
Foscavir
Synonyms
Foscarmet; Foscarnet; Phosphonoformate; Triapten; Virudin; Carboxyphosphonic acid; Dihydroxyphosphanecarboxylic acid oxide; Dihydroxyphosphinecarboxylic acid oxide; Dihydroxyphosphinecarboxylic acid oxide trisodium salt; Dihydroxyphosphinecarboxylic acid oxide trisodium salt hexahydrate; FOSCARNET SODIUM; Forscarnet sodium; Foscarnet sodico; Foscarnet sodico [Spanish]; Foscarnet sodique; Foscarnet sodique [French]; Foscarnet sodium hexahydrate; Foscarnet sodium hydrate; Foscarneto sodico; Foscarnetum natricum; Foscarnetum natricum [Latin]; Phgosphonocarboxylic acid; Phosphonoformic acid; Phosphonomethanoic acid; Trisodium carboxyphosphate; Trisodium dioxidophosphanecarboxylate oxide; Trisodium dioxidophosphinecarboxylate oxide; Trisodium phosphonatoformate; Trisodium phosphonatoformate hexahydrate; Trisodium phosphonoformate; Trisodium phosphonoformate hexahydrate; Trisodium phosphonoformte hexahydrate; A 29622; EHB 776; A-29622; DRG-0017; Dihydroxyphosphinecarboxylic acid oxide and MSL, neutralizing monoclonal antibody; EHB-776; Foscarnet sodique [INN-French]; Foscarnet sodium hydrate (JAN); Foscarneto sodico [INN-Spanish]; Foscarnetum natricum [INN-Latin]; Foscavir (TN); HS-0008; MSL & PFA; Phosphonoformic acid, trisodium salt; Trisodium carboxyphosphate (anhydrous); Trisodium phosphonoformate (anhydrous); Foscarnet & IFN-ALPHA; Foscarnet sodium (USAN/INN); Foscarnet sodium [USAN:INN:BAN]; Phosphonoformic acid & IFN-ALPHA; Phosphonoformic acid, trisodium salt, hexahydrate; PFA & rIFN.alpha.A; Phosphinecarboxylic acid, dihydroxy-, oxide; Phosphonoformate(trisodium) & Recombinant Alpha-A Interferon; Sodium dioxidophosphanecarboxylate oxide hydrate(3:1:6); Formic acid, phosphono-, trisodium salt, hexahydrate; Phosphinecarboxylic acid, dihydroxy-, oxide, trisodium salt; Phosphinecarboxylic acid, dihydroxy-, oxide, trisodium salt, hexahydrate
Drug Type
Small molecular drug
Indication Cytomegalovirus retinitis [ICD9: 78.5; ICD10:B25.8, H30.9] Approved [538537]
Therapeutic Class
Antiviral Agents
Company
AstraZeneca
Structure
Download
2D MOL

3D MOL
Formula
CNa3O5P
Canonical SMILES
C(=O)([O-])P(=O)([O-])[O-].[Na+].[Na+].[Na+]
InChI
1S/CH3O5P.3Na/c2-1(3)7(4,5)6;;;/h(H,2,3)(H2,4,5,6);;;/q;3*+1/p-3
InChIKey
DFHAXXVZCFXGOQ-UHFFFAOYSA-K
CAS Number
CAS 4428-95-9
PubChem Compound ID
44561
PubChem Substance ID
7847645, 8149794, 8178763, 10196943, 12012803, 14772938, 26612258, 26679458, 26748573, 26748574, 34709806, 48416037, 50006945, 50534151, 57312956, 57357103, 85341314, 91010671, 92124322, 92307785, 92714305, 99302003, 103202136, 104345184, 108146945, 113004708, 119526189, 124637846, 125312361, 125537224, 126622014, 126624248, 126645593, 126655507, 126669585, 135006490, 137267469, 144204917, 152090806, 160843930, 162177321, 162263575, 163134832, 164810490, 170465060, 179210376, 184545040, 196106557, 198969523, 223677244
SuperDrug ATC ID
J05AD01
Target and Pathway
Target(s) DNA polymerase Target Info Inhibitor [537140]
References
Ref 538537FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (NDA) 020068.
Ref 537140Drug targets in cytomegalovirus infection. Infect Disord Drug Targets. 2009 Apr;9(2):201-22.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.